Jazz Pharmaceuticals (NASDAQ: JAZZ) CEO donates 600 shares

Rhea-AI Filing Summary

Jazz Pharmaceuticals plc President & CEO Renee D. Gala reported a charitable share transfer. On June 3, 2026, she made a bona fide gift of 600 ordinary shares at a stated price of $0.00 per share, reducing her direct holdings to 152,196 shares. A footnote also notes that she acquired 166 ordinary shares through a Section 423 Employee Stock Purchase Plan on May 29, 2026, highlighting ongoing participation in employee equity programs.

Insider Trade Summary

600 shares gifted

Mixed 1 txn

Insider GALA RENEE D

Role President & CEO

Type	Security	Shares	Price	Value
Gift	Ordinary Shares	600	$0.00	--

Holdings After Transaction: Ordinary Shares — 152,196 shares (Direct, null)

Footnotes (1)

1. Shares were donated to The Gala Family Fund, a donor-advised fund. The Reporting Person acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 29, 2026.

Key Figures

Gifted shares: 600 ordinary shares Gift price: $0.00 per share Shares held after transaction: 152,196 ordinary shares +2 more

5 metrics

Gifted shares 600 ordinary shares Bona fide gift on June 3, 2026

Gift price $0.00 per share Stated price for gifted shares

Shares held after transaction 152,196 ordinary shares Direct holdings after June 3, 2026 gift

ESPP acquisition 166 ordinary shares Acquired under Section 423 ESPP on May 29, 2026

Gift type Bona fide gift (code G) Non-derivative transaction classification

Key Terms

bona fide gift, donor-advised fund, Section 423 Employee Stock Purchase Plan

3 terms

bona fide gift financial

"The transaction code is G, described as a bona fide gift."

A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.

donor-advised fund financial

"Shares were donated to The Gala Family Fund, a donor-advised fund."

A donor-advised fund is a charitable giving account that lets an individual or family deposit cash, stock, or other assets now, get an immediate tax benefit, and then recommend grants to charities over time. Think of it like a private charitable bucket you control without running a charity yourself; investors care because it’s a tax-efficient way to give appreciated securities, can change when and how donated shares enter the market, and affects personal and corporate tax planning.

Section 423 Employee Stock Purchase Plan financial

"The Reporting Person acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 29, 2026."

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GALA RENEE D

(Last) (First) (Middle)

5TH FL, WATERLOO EXCHANGE

WATERLOO RD

(Street)

DUBLIN 4

(City) (State) (Zip)

IRELAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
Jazz Pharmaceuticals plc [ JAZZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President & CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	06/03/2026		G(1)		600	D	$0.0	152,196(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares were donated to The Gala Family Fund, a donor-advised fund.

2. The Reporting Person acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 29, 2026.

	By: /s/Paz Dizon, as attorney in fact For: Renee D. Gala	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Jazz Pharmaceuticals (JAZZ) report for Renee D. Gala?

The filing reports that President & CEO Renee D. Gala made a bona fide gift of 600 ordinary shares on June 3, 2026. This transfer was reported at a stated price of $0.00 per share and reflects a charitable disposition, not a market sale.

How many Jazz Pharmaceuticals (JAZZ) shares does Renee D. Gala hold after the gift?

After the June 3, 2026 gift of 600 ordinary shares, Renee D. Gala’s direct holdings total 152,196 ordinary shares. This figure comes directly from the post-transaction ownership line in the Form 4 and shows she retains a substantial equity position.

Was the Jazz Pharmaceuticals (JAZZ) CEO’s 600-share transaction a sale or a gift?

The transaction was a bona fide gift of 600 ordinary shares, not a sale. The Form 4 uses transaction code G and describes the action as a gift transfer, with a stated price of $0.00 per share, indicating no market consideration was received.

Who received the 600 Jazz Pharmaceuticals (JAZZ) shares gifted by the CEO?

The 600 ordinary shares were donated to The Gala Family Fund, a donor-advised fund. This is disclosed in a Form 4 footnote, clarifying that the shares were transferred for charitable purposes rather than sold in the open market.

Did the Jazz Pharmaceuticals (JAZZ) CEO recently acquire shares through an employee plan?

Yes. A footnote states that Renee D. Gala acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 29, 2026. This indicates ongoing participation in the company’s employee stock purchase program alongside the reported charitable gift.